PRGO logo

PRGO Perrigo Company plc

New York Stock Exchange · Drug Manufacturers - Specialty & Generic · Healthcare

$15.94
-0.10 (-0.62%)

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral…

Market Cap: $2.21Bwww.perrigo.com

Price

$12.84+7.72%
$9.49$10.75$12.01$13.27
May 1Aug 7

Social Signal Score

50
5d
—
30d
52
8 mentions
+0.0%
60d
50
11 mentions
+0.0%
90d
48
14 mentions
+0.0%
news: 14

Analyst Ratings

36 analysts
Holdconsensus
Strong Buy 0Buy 14Hold 21Sell 1Strong Sell 0
Avg price target$36.2+127.1%
Low $20Median $36High $54
Current Consensus

Revenue

$988.60M-6.87%
$948.80M$1.07B$1.20B$1.32B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$2.77
$2.75–$2.80
4 analysts
FY2026
$2.29-18% YoY
$2.26–$2.31
2 analysts
FY2027
$2.31+1% YoY
$2.29–$2.33
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Albert A. Manzone
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8,100
Beta
0.54
Country
IE
Piotroski score
4 / 9 (Middling)
Altman Z-score
-0.39
www.perrigo.com